Document:

<PAGE>
                                                                    Exhibit 10.2

                          WINDHAM INDUSTRIAL CENTER V
                              ROMEOVILLE, ILLINOIS

                            FIRST AMENDMENT TO LEASE

                                    BETWEEN

                  THE PRUDENTIAL INSURANCE COMPANY OF AMERICA,
                           A NEW JERSEY CORPORATION,
                                    LANDLORD

                                      AND

                             INNOTRAC CORPORATION,
                             A GEORGIA CORPORATION,
                                     TENANT

--------------------------------------------------------------------------------
                               CONCESSION GRANTED

   Portions of Base Rent shall abate hereunder for up to four (4) months. See
                                Section 3 below.
--------------------------------------------------------------------------------
<PAGE>
                            FIRST AMENDMENT TO LEASE

     THIS FIRST AMENDMENT TO LEASE (the "First Amendment") is made as of the 4th
day of April 2003, by and between THE PRUDENTIAL INSURANCE COMPANY OF AMERICA, a
New Jersey corporation ("Landlord"), and INNOTRAC CORPORATION, a Georgia
corporation ("Tenant").

                                  WITNESSETH:

     WHEREAS, Landlord and Tenant have heretofore entered into that certain
lease dated as of September 17, 2002 (the "Lease"), pursuant to which Tenant is
leasing approximately 150,204 square feet of rentable area (the "Existing
Premises") in the building located at 1400-1420 Lakeview Drive in Romeoville,
Illinois (the "Building"). Capitalized terms that are not otherwise defined in
this First Amendment shall have the meanings ascribed to them in the Lease;

     WHEREAS, Tenant desires to lease from Landlord and Landlord desires to
lease to Tenant an additional 54,103 square feet of gross rentable area adjacent
to the Existing Premises;

     NOW, THEREFORE, in consideration of the foregoing and for other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows:

     1.  Additional Premises.  As of April 1, 2003 (the "Effective Date"),
Landlord hereby leases to Tenant, and Tenant hereby accepts from Landlord, the
54,103 square feet of gross rentable area in the Building depicted as the "First
Addition" on Exhibit A attached hereto and made a part hereof (the "Additional
Premises") for the Term. For all periods from and after the Effective Date,
Exhibit A to the Lease shall be superseded by Exhibit A attached hereto and
made a part hereof. From and after the Effective Date the Premises shall consist
of both the Existing Premises and the Additional Premises, constituting 204,307
square feet of rentable area in the aggregate. From and after the Effective
Date, all references to the Premises in the Lease shall be deemed to refer to
the Existing Premises and the Additional Premises.

     2.  Base Rent and Tenant's Proportionate Share.

     (a)  For all periods from and after the Effective Date, Section 1.09 of
the Lease shall be superseded by Exhibit B attached hereto and made a part
hereof.

     (b)  As of the Effective Date Tenant's Proportionate Share under the Lease
shall be 45.30% (rather than 33.31%).

     3.  Rent Abatement.  Notwithstanding anything to the contrary contained in
the Lease or this First Amendment, and provided that Tenant is not then in
default under the Lease (as amended by this First Amendment), Base Rent shall
abate, and Tenant shall have no liability therefor: (a) in an amount equal to
$16,185.81 otherwise payable for April 2003; and (b) in an

                                      -2-
<PAGE>
amount equal to $8,092.91 otherwise payable for each of the months of May 2003,
June 2003 and July 2003. Landlord and Tenant agree that no portion of the Base
Rent paid by Tenant during the portion of the Term occurring prior to or after
the expiration of any period during which such Base Rent was abated shall be
allocated, for income tax purposes, nor is such Base Rent intended by the
parties to be allocable, for income tax purposes, to any abatement period.

     4.   Possession of the Additional Premises. No promise of Landlord to
alter, remodel or improve the Premises, the Additional Premises or the
Property, and no representation respecting the condition of the Premises, the
Additional Premises or the Property, has been made by Landlord to Tenant.
Tenant hereby accepts the Additional Premises in their "as is" condition.

     5.   Expansion Space.

     (a)  Landlord and Tenant hereby acknowledge and agree that Section 29 of
the Lease are hereby deleted in their entirety, and Tenant shall have no
further rights under such provisions.

     (b)  If Landlord and Tenant shall enter into an additional amendment to
the Lease on or before January 31, 2004, pursuant to which: (i) Tenant leases
all, and not less than all, of the 51,254 square feet of gross rentable area in
the Building depicted as the "Expansion Space" on Exhibit A attached hereto and
made a part hereof (the "Expansion Space") for the remainder of the Term; and
(ii) Tenant accepts the Expansion Space in its then current "as is" condition,
and pursuant to such other terms and conditions upon which Landlord and Tenant
shall mutually agree in their respective sole and absolute discretion, then
Landlord shall make the $90,000 TI Allowance available to Tenant in accordance
with Section 9.2 of the Lease and Section 5 of the Work Letter.

     (c)  If the condition precedent described in Section 5(b) shall not have
been satisfied on or before January 31, 2004, and:

          (i)  Landlord leases all of the Expansion Space to a tenant other than
     Tenant, then, (x) Landlord shall construct a standard demising wall between
     the Premises (as expanded under this First Amendment) and the Expansion
     Space at Landlord's sole cost and expense; and (y) Landlord shall be
     required to pay up to the $90,000 TI Allowance to Tenant solely to
     reimburse Tenant for all reasonable costs and expenses of Tenant relating
     to the construction of the office space to be located in the Premises and
     described in Schedule 1 to the Work Letter, and for no other costs and
     expenses; or

          (ii) Landlord shall lease all or a portion of the Expansion Space to
     Tenant (other than in accordance with Section 5(b) above), then Section 9.2
     of the Lease and Section 5 of the Work Letter shall be amended such that
     the term "TI Allowance" shall be defined as "zero dollars ($0.00)."

     6.   Real Estate Broker. Other than with respect to Insignia/ESG (the
"Broker"), insofar as each party knows, no other broker negotiated this First
Amendment or is entitled to any commissions in connection herewith. Each party
agrees to indemnify, defend and hold the other and its employees, agents and
their officers and partners harmless from and against any claims resulting from
a breach of the foregoing representation. Landlord agrees to pay a

                                      -3-
<PAGE>
commission to Broker in connection with this First Amendment pursuant to a
separate agreement.

     7.   Full force and Effect, Inconsistency. Except as set forth in this
First Amendment, the terms, covenants, conditions and agreements of the Lease
shall remain unmodified and otherwise in full force and effect. In the event of
any inconsistency between the terms of the Lease and the terms of this First
Amendment, the terms of this First Amendment shall control.

        [The remainder of this page has been left blank intentionally.]

                                     - 4 -

<PAGE>
     IN WITNESS WHEREOF, the parties hereto have executed this First Amendment
as of the day and year first above written.

                                   LANDLORD:

                                   THE PRUDENTIAL INSURANCE COMPANY
                                   OF AMERICA,
                                   a New Jersey corporation

                                   By:  PDC Properties, Inc., its agent

                                   By: /s/ Rex Davis
                                   Name:  Rex Davis
                                   Title: Alliance Manager

                                   TENANT:

                                   INNOTRAC CORPORATION,
                                   a Georgia corporation

                                   By: /s/ David L. Gamsey
                                   Name:  DAVID L. GAMSEY
                                   Title: CFO

                                     - 5 -

<PAGE>
                                   Exhibit A

                                    Premises

                                      -6-
<PAGE>
                                   Exhibit B

                         Schedule of Base Rent Payments

<Table>
<Caption>

Lease Year                  Annual Base Rent          Total Annual Base Rent        Monthly Installments
----------                  ----------------          ----------------------        --------------------
<S>                         <C>                       <C>                           <C>
4/1/03 through the end of
1st Lease Year               $3.59 per square foot     $733,462.13                   $61,121.84
2nd Lease Year               $3.70 per square foot     $755,935.90                   $62,994.66
3rd Lease Year               $3.81 per square foot     $778,409.67                   $64,867.47
4th Lease Year               $3.92 per square foot     $800,833.44                   $66,740.29
5th Lease Year               $4.04 per square foot     $825,400.28                   $68,783.36
6th Lease Year               $4.16 per square foot     $849,917.12                   $70,826.43
</Table>

                                      -7-<PAGE>
                                                                   EXHIBIT 10.67

Dear Mr. Smith:

This letter is to confirm our mutual agreement with respect to the terms and
conditions under which Gerald Smith and Associates, Inc. and Gerald Smith
(individually) (together hereinafter known as "Consultant") agree to provide
ViraGenics (Viragen Inc.'s wholly owned subsidiary), directly or through its
subsidiaries, affiliated and associated companies, with services in a consulting
capacity during the period beginning February 1, 2003 and ending January 31,
2004 (hereinafter referred to as the "CONSULTING PERIOD"), it being understood
that this CONSULTING PERIOD shall be extended unless written notice of
termination is delivered by either party one to the other ninety (90) days prior
to the expiration of the CONSULTING PERIOD or upon the annual anniversary
thereof.

1.       "Consulting capacity" herein means that Consultant will provide
         VIRAGENICS with the full benefit of his knowledge, experience and skill
         with respect to all questions and projects, which VIRAGENICS will
         stipulate. During the term of this Agreement, Consultant shall provide
         advice to, consult with, and perform services for the Company. In this
         regard, the Company will submit any and all new projects it proposes
         for your review, acceptance or rejection. You agree to notify the
         Company as to your acceptance or rejection of your involvement as a
         consultant in any new project within fifteen (15) days from the date of
         VIRAGEN's submission to you.

VIRAGEN and VIRAGENICS acknowledge that other clients may use your consulting
services and it is understood and agreed that you are not to disclose to VIRAGEN
any confidential information of other parties, including past and present
clients. VIRAGEN will rely upon your ethical judgment to avoid conflicts of
interest. It is understood and agreed that during the CONSULTING PERIOD you
shall not consult for other parties on Avian Transgenics or leukocyte derived
and/or lymphoblastoid derived human interferon alpha and on monoclonal
antibodies for the treatment of melanoma. 2.

3.       During the Consulting Period, VIRAGEN agrees to pay Consultant at the
         rate of $12,916.67 per month, payable semimonthly. In the event that
         consulting services are provided at a location away from the
         metropolitan area of Consultant's regular place of business, VIRAGEN
         will reimburse Consultant for reasonable travel and living expenses
         incurred. It is understood and agreed that VIRAGEN will stipulate in
         advance in writing the places and locations where Consultant will
         provide services. Payment for Consultant's services and expenses will
         be made upon submission and approval to VIRAGEN of an itemized account
         of expenses incurred and payments due. All payments shall be made by
         check payable to Gerald Smith and Associates, Inc.

4.       During the discussions leading up to this Agreement, including
         Consultants prior employment with Viragen, Inc. and during the
         CONSULTING PERIOD and any extensions thereof Consultant has acquired
         and will continue to acquire from VIRAGEN information which VIRAGEN
         considers to be proprietary and confidential, for example, information
         with respect to materials, compounds, formulations, samples, processes,
         methods, apparatus, operations, clinical trial plans and results and
         present and future plans of VIRAGEN. Consultant agrees to keep
         confidential and not to use, except in connection with services in a
         consulting capacity provided to VIRAGEN, all such information, as well
         as all information developed as a result of Consultant's services to
         VIRAGEN under this Agreement, and not to divulge any such information

<PAGE>

Page 2 of 3

         to others at any time. Upon termination of this Agreement or at any
         other time VIRAGEN requests, Consultant will transmit to VIRAGEN any
         written, printed or other materials embodying such information,
         including all copies, excerpts thereof, and samples given or prepared
         in connection with work performed for VIRAGEN under this Agreement.
         These obligations with respect to VIRAGEN information shall continue at
         all times beyond the CONSULTING PERIOD and any extensions thereof.

         Notwithstanding the above, this Agreement shall not restrict
         Consultant's use or disclosure of information which:

                  (1)      is or later becomes publicly known through no fault
                           of Consultant;

                  (2)      was already known to Consultant (other than through
                           Consultant's previous employment by VIRAGEN) as
                           evidenced by written records at the time of its
                           receipt from VIRAGEN; or

                  (3)      is lawfully and in good faith made available to
                           Consultant without restriction on disclosure or use
                           by a third party.

         Specific information disclosed by VIRAGEN shall not be deemed to be
         available to the public or in your prior possession merely because it
         is embraced by more general information available to the public or in
         Consultant's prior possession.

5.       Any and all information, inventions and discoveries, whether or not
         patentable, which Consultant develops, conceives and/or makes as a
         result of confidential information received from VIRAGEN shall be the
         sole and exclusive property of VIRAGEN. Consultant will, upon request
         of VIRAGEN, promptly execute any and all applications, assignments or
         other instruments which VIRAGEN shall deem necessary or useful in order
         to apply for and obtain patent protection worldwide for said inventions
         and discoveries, and in order to assign and convey to VIRAGEN the sole
         and exclusive right, title and interest in and to said inventions and
         discoveries and patent applications and patents thereon. VIRAGEN will
         bear the costs of preparation and filing of all said patent
         applications.

6.       While providing services for VIRAGEN Consultant will be acting as an
         independent contractor and not as an employee or agent of VIRAGEN and
         will not be entitled to any of the benefits, direct or indirect, of an
         employee of VIRAGEN other than reimbursement of group health insurance
         costs and an automobile and related expenses during the term of this
         Agreement.

7.       The validity, interpretation and performance of this Agreement and any
         dispute connected herewith shall be governed and construed in
         accordance with the laws of the State of Florida, USA.

8.       Consultant will not be liable for any loss, injury or damage incurred
         by VIRAGEN or by a third party as a result of performance of the
         consulting services, including any loss, injury or damage resulting
         from the negligent or willful act or omission by VIRAGEN. VIRAGEN shall

<PAGE>
Page 3 of 3

         indemnify and hold Consultant harmless from any liability, loss, cost,
         and expense (including attorneys' fees and costs) incurred as a result
         of VIRAGEN's breach of this agreement, negligence or willful
         misconduct. This obligation shall survive the expiration or earlier
         termination of this agreement.

9.       Consultant hereby certifies that Consultant will not or has not
         employed or otherwise used in any capacity the services of any person
         debarred under Section 306(a) or (b) of the Federal Food, Drug, and
         Cosmetic Act in performing any services hereunder.

10.      This agreement contains the entire understanding between and among the
         parties and supersedes any prior understanding and agreement among them
         including, but not limited to, Consultant's Employment Agreement dated
         March 1, 2001.

11.      Arbitration. The parties hereto desire to avoid and settle without
         litigation future disputes that may arise between them relative to this
         Agreement. Accordingly, the parties agree to engage in good faith
         negotiations to resolve any such dispute. In the event they are unable
         to resolve any such dispute by negotiation, such dispute shall be
         submitted to arbitration in Miami, Florida in accordance with the rules
         of the State of Florida. The arbitration award shall be final and
         binding on the signatories hereto and may be filed with and enforced by
         any court of competent jurisdiction. The prevailing party shall be
         reimbursed by the other for all legal fees connected therewith. In the
         event that the parties cannot agree upon the venue as provided for
         herein, within THIRTY (30) DAYS from the date a party has notified the
         other of the need for arbitration then each party shall have the right
         to pursue any claim and to litigate within the court system in the
         State of Florida.

12.      The parties hereto cannot assign this Agreement.

If the foregoing terms and conditions meet with your understanding and approval,
please show your acceptance and agreement by signing this letter in duplicate at
the place indicated below.

Very truly yours,

VIRAGEN, INC.
VIRAGENICS, INC.

By: /s/ CARL N. SINGER               By:   /s/ GERALD SMITH
    --------------------                   -----------------------------------
    Carl N. Singer                   Name: Gerald Smith, President
    Chairman                               Gerald Smith & Associates, Inc.
                                           and individually

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00051-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00051-of-00352.parquet"}]]